Some pathological changes have been reported to result from NAT in pancreatic cancer patients, e.g., acellular mucous pools, macrophage aggregation, calcification, and a clear-cell variant of cancer.[14] We found that these findings are uncommon in GnP patients; therefore, they are not useful as prognostic markers. The gene discussed is BRD2; the disease is cancer.